cause of bloodstream infections (BSIs) and directly threatens the health and life of cancer patients. 3 K. pneumoniae is an important opportunistic pathogen, and it has been a leading healthcare-acquired infection (HAI) agent worldwide for decades. Since the mid1980s, reports from the Asian Pacific Rim have described a unique clinical syndrome of community-acquired, tissueinvasive K. pneumoniae infection in healthy individuals. 4 These strains often present in multiple sites or metastatically spread but are sensitive to antibiotics. Currently, K. pneumoniae shows high resistance to a broad spectrum of drugs, including β-lactam antibiotics, aminoglycosides and fluoroquinolones. 5, 6 Notably, carbapenem-resistant and hypervirulent K. pneumoniae strains have emerged recently. 7 These strains are both hypervirulent and multidrug-resistant, and they may also be highly transmissible and able to cause severe infections in both the hospital and the community. A group found that the cancer patients with long hospital stay and previous antibiotics use were more easily infected with ESBL-K. pneumoniae. 8 It increased the difficulty to combat K. pneumoniae infection for the currently available antibiotics. The limited treatment options of antibiotics impose high mortality rates, prolonged hospitalization and costs on public healthcare. 9 The aim of this study was to investigate the molecular epidemiology characteristics of K. pneumoniae collected from lung cancer patients with respiratory infection during an outbreak in a cancer hospital in China and to provide insights into the prevention and control of this nosocomial infection.
Methods

Identification of Patients
This retrospective study was conducted in the Nantong Tumor Hospital, a 1200-bed tertiary hospital with about 9000 new cases per year in Nantong, East China. In this hospital, about 1400 lung cancer patients were admitted to medical oncology per year. About 10% of the 1400 lung cancer patients were accompanied with respiratory infection. From September 2017 to October 2018, patients who satisfied the symptoms of respiratory infection were screened for bacterial isolates by culturing sputum, blood, pleural cavity or excretion. 10 The inclusion and exclusion criteria of samples are in the Supplementary information. The relevant clinical and microbiological data were extracted from electronic or paper medical records and microbiological databases. This study was reviewed and approved by the Ethics 
DNA Extraction and Antibiotic
Resistance Gene Detection DNA templates were extracted using the boiling lysis method described previously. 12 The detection of resistance genes was performed by PCR, and their identities were confirmed by sequencing. Isolates were screened by PCR amplification using specific primers for the detection of extended-spectrum β-lactamase (ESBL)-encoding genes (blaTEM, blaSHV, blaOXA-1, blaOXA-4, blaOXA-30 and blaCTX-M), 13 carbapenemase genes (blaKPC, blaVIM, blaIMP, blaNDM, and blaOXA-48), 14 a tigecycline resistance determinant (tet (A)), 15 and colistin resistance genes (mcr-1, 2, 3, 4, and 5). 16 The specific primers and the length of the expected PCR products are presented in Supplementary Table 3 . Amplicons were analyzed by gel electrophoresis in 2% agarose and visualized under ultraviolet (UV) light. The forward primers were used for DNA sequencing.
String Test and Infection of G. mellonella Larvae
The string test was considered indicative of a hypermucoviscous K. pneumoniae isolate if the inoculation loop was able to generate a viscous string 5 mm in length while stretching a single colony away from an overnight culture agar plate containing 5% sheep blood. 17 The virulence of K. pneumoniae isolates was evaluated in vivo using a G. mellonella larvae infection model performed as previously described. 18 Briefly, K. pneumoniae isolates were grown in 1 mL LB broth, harvested during exponential phase, and washed once with 10 mM phosphate-buffered saline (PBS; pH 7.4). Isolates were diluted in PBS to a McFarland turbidity of 0.5, which corresponds to approximately 1×10 8 CFU/mL. After surface disinfection, larvae were injected with 10 μL of bacterial suspension, containing approximately 1×10 7 CFU/mL, into the last right proleg by use of a Gas Chromatogram syringe with a 30-gauge needle. A group of 10 larvae were injected with 10 μL of PBS in parallel to ensure that death was not due to injection trauma. Larvae were placed in 9-cm petridishes with food and kept at 37°C in the dark. Insects were considered dead when they did not respond to physical stimuli. Time of death was recorded. Assays were allowed to proceed for only 72 hrs. At least two independent experiments were performed.
Serotype and Virulence-Associated Gene Detection
PCR was used to detect the presence of capsule serotypes (K1 and K2) and virulence-associated genes. These virulence-associated genes included those encoding regulators of mucoid phenotype A (rmpA), K1 serotype (magA), enterobactin (entB), yersiniabactin (ybtS), phenolate-type siderophore (kfu), the aerobactin siderophore system (iutA), type 3 adhesins (mrkD), allantoin metabolism-associated genes (allS), peg-344, iroB, iucA, and the K2 capsular serotypespecifying wzi gene (Supplementary Table 2 ). Isolated DNA samples were screened using specific primers for the detection of virulence genes. 11, 19, 20 The forward primers were used for DNA sequencing.
Statistical Analysis
Data were analyzed by SAS (V9.01). Continuous variables were described as mean ± SD and categorical variables as No (percentage). T-test process was conducted for normal distribution continuous data, while Chi-square or Fisher's exact analysis was for categorical data. P-value <0.05 was considered as statistical significance.
Results
Frequency of K. pneumoniae in Lung Cancer Patients with Respiratory Infection
From September 2017 to October 2018, 260 lung cancer cases with cough and fever were collected. After excluding 213 nonrespiratory infections cases, there were 47 respiratory infection cases to be processed. As a result, a total of 60 clinical samples were collected from the 47 cases. The 60 clinical samples were composed of 47 sputum samples, 8 blood samples, 3 hydrothorax samples, 1 ascites sample and 1 secreta sample. One representative sample was taken from one-sampled isolates sharing the same PFGE patterns and MIC phenotypes. Thus, 37 nonduplicate K. pneumoniae strains were collected. These 37 K. pneumoniae strains were isolated from 27 of the 47 (57.45%) patients tested ( Figure 1 (Table 1) . Twelve isolates (31.1%) were found to be resistant to polymyxin B; however, the mcr-1, 2, 3, 4, and 5 genes were not detected in any of the isolated strains. In addition, tigecycline susceptibility was reduced in some strains, with an MIC ≥ 0.5 µg/mL (64.9%).
Acquired β-lactamase genes were detected in most isolates with a ceftazidime MIC ≥ 4 µg/mL. bla CTX-Mtype and bla SHV genes were found to be dominantly carried in all these isolates. Fifteen of the 18 aztreonamresistant K. pneumoniae isolates carried bla TEM . Two isolates of carbapenem-resistant K. pneumoniae (CRKP) carried the bla KPC-2 gene. Among the 37 isolates tested, we found that 20 strains carried the tet(A) variant, accounting for 54.1% of the test isolates. These 20 strains were all resistant to tetracycline with high MIC values. The tigecycline MIC values of strains harboring the tet(A) variant were mostly ≥0.5 µg/mL (18/20; 90.0%). Interestingly, all pulsotype I and J isolates harboring blaCTX-M were found to harbor the tet(A) gene (Figure 2 ).
Virulence-Associated Features
All K. pneumoniae isolates were subjected to string tests to determine their virulence level, with results showing that 16 of the 37 strains (43.2%) were positive for the test. The virulence genes peg-344, iroB, iucA, and rmpA were detected as markers for identifying hypervirulent K. pneumoniae (HvKP) strains. 20 hypervirulent marker genes. Two virulence-encoding genes were detected (entB and mrkD) in all isolates. Additionally, the rmpA gene was found in 27.0% (10/37), the iutA gene in 27.0% (10/37), the allS gene in 13.5% (5/ 37), the kfu gene in 18.9% (7/37), the ybtS gene in 43.2% (16/37), and the iucA gene in 94.6% (35/37). KP10.1, KP14.2, KP28.1, KP37.1, KP49, KP54.1, and KP63.1 were selected as representative isolates according to PFGE patterns and MIC phenotypes and then subjected to further assessment of virulence potential using a G. mellonella larvae infection model, using an inoculum of 1×10 5 CFU per larva. The hypermucoviscous strain of K. pneumonia ATCC43816 was used as a hypervirulentreference strain. As shown in Figure 3 , it was clear that the death rate caused by strains isolated from this hospital was higher than that of ATCC43816 by 24 hrs, 48 hrs, and 72 hrs. Notably, not all strains from different patients showed consistent virulence.
Clonal Relationship of K. pneumoniae Strains
To investigate whether K. pneumoniae strains were clonally transmitted within this hospital and identify the prevalent clones, all 37 isolates were subjected to XbaI-PFGE and MLST analyses. With 80% genetic similarity as the cutoff, a total of 17 different pulsotypes were identified (Figure 2) , while strain KP57.1 was untypable and did not give any bands. The most predominant pulsotype was pulsotype I (27.0%), followed by pulsotypes E (13.5%) and H (10.8%). In addition, there were seven PFGE patterns represented by a single strain. Strains isolated from different patients often showed diverse PFGE profiles, suggesting that K. pneumoniae isolates had diverse genetic backgrounds. The predominant pulsotype I consisted of 10 strains containing bla CTX and bla SHV genes obtained from June 12, 2018 to July 12, 2018. The pulsotype E strain also harbored 5 β-lactam-resistant MDR strains isolated from September 13, 2018 to October 12, 2018. The pulsotype H consisted of four hypervirulent ST23 K. pneumoniae isolates. The two ST11 CRKP isolates belonged to pulsotype K. The similarity of PFGE patterns of K. pneumoniae from different patients suggested that clonal transmission was observed in the hospital ( Figure 3 ). We also found that one patient could carry various K. pneumoniae isolates harboring different phenotypes and genetic diversity at the same time, exhibiting the coexistence of hypervirulence and low virulence or coexistence of MDR strains and sensitive strains.
Discussion
Globally, lung cancer is the most common cancer, contributing to one in five cancer deaths. 21 Although the operative mortality after lung resection has decreased over the past decades, the mortality rate from postoperative pneumonia following lung cancer surgery remains significant. 22 Patients with cancer are more likely to suffer from infection due to pathogenic bacteria than benign patients.
23
K. pneumoniae is a leading cause of lung infection in hospitalized patients. 24 High mortality is closely related to healthcare-associated acute infection due to KPC-K. pneumoniae in cancer patients. 25 However, the epidemiology characteristics of K. pneumoniae in lung cancer patients with respiratory infection are unclear. The present study showed important information regarding the current status of the frequency and transmission kinetics of respiratory infection due to K. pneumoniae in lung cancer patients in a cancer hospital. Our data showed that K. pneumoniae were the dominant strain causing lung infection in lung cancer patients, with an isolation rate of 57.45%, exhibiting a wide distribution of genetic diversity among the 37 K. pneumoniae strains. ESBL-encoding genes, carbapenemase genes, a tigecycline-resistance determinant and colistin resistance genes which covered the graveconcerned genes for the treatment of K. pneumoniae infections were screened here. 26 ESBL-carrying K. pneumoniae isolates; there seems to be an intimate connection between the occurrence of ESBLcarrying and MDR K. pneumoniae. Carriage of ESBL genes contributes to high mortality, prolonged length of hospital stay and high cost in hospitals. Globally, 14% of healthy individuals are colonized with ESBL Enterobacteriaceae. 27 The frequency of ESBL-K. pneumoniae in our study was higher in lung cancer patients than in the healthy population. 28 The most common determinants were the bla CTX-M , bla SHV and bla TEM genes in two dominant pulsotypes, which have been reported to be the most frequent ESBLs in K. pneumoniae isolates. 26 Epidemiological studies suggest that the increasingly widespread occurrence of CRKP has become a major public health crisis. 29 In our study, ST11 CRKP strains were isolated from two patients, and these strains could bring difficulties for infection control if the hospital does not prevent the transmission of CRKP. The high rates of resistance to polymyxin B and the prevalence rate of tet(A) variant genes found in this study deserve particular attention because these antibiotic categories have typically been used as the drugs of last resort for the treatment of severe infections caused by CRKP. High rates of resistance to polymyxin B and tet(A) variant genes mediating reduced tigecycline susceptibility of CRKP or Salmonella enterica were reported in other previous studies. 15, 30 A hypervirulent variant of K. pneumoniae has emerged worldwide. 17 Since hypervirulent K. pneumoniae often confers the hypermucoviscous (HM) phenotype, we conducted a string test of 37 isolates. The positive rate of hypermucoviscous K. pneumoniae was 43.2%. The virulent serotype K1 and K2 HM strains were isolated. Then, representative strains of different genotypes and phenotypes (including hypermucoviscous and nonhypermucoviscous strains) were subjected to a G. mellonella infection model. Notably, all the K. pneumoniae strains were demonstrated to be highly virulent in the G. mellonella infection model. A review has suggested that HM and hypervirulence are two distinct phenotypes of K. pneumoniae that should not be used synonymously. 31 Our results may be caused by the high prevalence rate of the iucA gene, which is one of the biomarkers for hvKP. 20 In addition, diverse drug resistance and virulent phenotype K. pneumoniae strains were isolated, including typical ST23 hypervirulent K. pneumoniae, ESBL-producing HMKP, MDR classical K. pneumoniae, polymyxin B-resistant HMKP, tigecyclineresistant K. pneumoniae and ST11 CRKP. In order to control MDR K. pneumoniae infection, we conduct measures as followed. Firstly, the pre-screening of MDR isolates and active surveillance for lung cancer patients will be protocolled. Secondly, we implement stringent isolation procedures for MDR isolates-bearing patients, and earlytargeted therapies were used to kill the MDR isolates according to the MIC results. Thirdly, it would be essential to separate the MDR-isolates patients in isolation wards.
Conclusion
Although the sample size of this study is limited, this is the first report of the molecular epidemiology of K. pneumoniae in lung cancer patients with respiratory infection in Nantong, eastern China. Our study highlights the urgent need to enhance the clinical prevention and management of K. pneumoniae, especially the MDR hypervirulent isolate-causing respiratory infection in cancer hospitals. Careful and continued surveillance of K. pneumoniae strains and enhanced control measures are needed during the hospitalization of cancer patients.
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